WebNov 10, 2024 · 2.1 Patients. A prospective cohort of renal transplant recipients were recruited and received a standard immunosuppression protocol similar to the Symphony Trial (Reference cohort, Figure 1A, EuDra CT No 2011-004301-24). 16 This Reference cohort generated baseline clinical and immunological outcome data to act as comparator to the … WebSep 17, 2024 · The SYMPHONY trial showed that de novo SRL use without CNI was associated with higher rates of acute graft rejection and poor kidney function compared …
National Center for Biotechnology Information
WebJun 1, 2009 · In the ELITE Symphony trial [26], low TAC trough levels were targeted (3-7 ng/ml) during the first year post-transplant; however, the study patients achieved higher average trough level of 6-8 ng/ml. WebMar 22, 2011 · Sixty-six renal transplant recipients of eight Spanish centres took part in the Pharmacokinetic Symphony substudy. Patients were originally randomized into four branches of immunosuppressive regimen, all of them consisting of daclizumab induction, MMF and corticosteroids potentiated by either low dose of cyclosporine (CsA) or … cytoplasmic antibodies present
Feasibility, long‐term safety, and immune monitoring of regulatory …
WebOct 27, 2014 · The SYMPHONY Trial Sibrafiban Versus Aspirin to Yield Maximum Protection from Ischemic Heart Events Post-acute Coronary Syndromes Reference Reddan DN, et al. … WebTRANSFORM (TRANSplant eFficacy and safety Outcomes with an eveRolimus-based regiMen) was a 24-month, prospective, open-label trial in 2037 de novo renal transplant … WebNov 18, 2016 · In this open-label, multicentre, randomised controlled trial, we randomly assigned renal transplant recipients in a 1:1:1 ratio to receive either basiliximab induction … bing crosby merry christmas album vinyl